Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer

Oncology Letters

Volumn 10, Issue 1, 2015, Pages 291-296

  Huang, Cheng ^a   Cao, Lihua ^b   Qiu, Limin ^c   Dai, Xiaoli ^a   Ma, Linwei ^a   Zhou, Yingting ^a   Li, Huifen ^a   Gao, Min ^a   Li, Weiyong ^a   Zhang, Qing ^a   Han, Koulan ^a   Lv, Hongzhen ^a  

^a YANCHENG INSTITUTE OF TECHNOLOGY   (China)

^b Departments of Dermatology   (China)

^c NANTONG MEDICAL COLLEGE   (China)

Author keywords

Epithelial to mesenchymal transition; Esophageal cancer; H19; Invasion; Proliferation

Indexed keywords

RNA H19; SMALL INTERFERING RNA; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGUS CANCER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MTT ASSAY; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SAMPLING; SEQUENCE ANALYSIS; TRANSWELL ASSAY; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING;

EID: 84929869473     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3165     Document Type: Article

References (25)

1. Zhang F, Yang Z, Cao M, et al: MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett 342: 121-129, 2014.
2. Wang F, Li X, Xie X, Zhao L and Chen W: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 582: 1919-1927, 2008.
3. Wu ZH, Wang XL, Tang HM, et al: Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep 32: 395-402, 2014.
4. Li H, Yu B, Li J, et al: Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget 5: 2318-2329, 2014.
5. Gutschner T, Hämmerle M, Eissmann M, et al: The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73: 1180-1189, 2013.
6. Wang Y, Wen M, Kwon Y, et al: CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res 74: 520-531, 2014.
7. Liu J, Ruan B, You N, et al: Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells. PLoS One 8: e79409, 2013.
8. Dong H, Xie L, Tang C, et al: Snail1 correlates with patient outcomes in E-cadherin-preserved gastroesophageal junction adenocarcinoma. Clin Transl Oncol 16: 783-791, 2014.
9. Liu Y, Li H, Feng J, et al: Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells. PLoS One 8: e83083, 2013.
10. Bao YX, Cao Q, Yang Y, et al: Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC). Diagn Pathol 8: 197, 2013.
11. Li W, Jiang G, Zhou J, et al: Down-regulation of miR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer. Cell Physiol Biochem 34: 1466-1476, 2014.
12. Hibi K, Nakamura H, Hirai A, et al: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482, 1996.
13. Shigaki H, Baba Y, Watanabe M, Murata A, Ishimoto T, Iwatsuki M, Iwagami S, Nosho K and Baba H: PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma. Clin Cancer Res 19: 2451-2459, 2013.
14. Koshy M, Esiashvilli N, Landry JC, Thomas CR Jr and Matthews RH: Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist 9: 147-159, 2004.
15. Yang X, Song JH, Cheng Y, et al: Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 63: 881-890, 2014.
16. Ge XS, Ma HJ, Zheng XH, et al: HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci 104: 1675-1682, 2013.
17. Kitamura K, Seike M, Okano T, et al: MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther 13: 444-453, 2014.
18. Guo S, Xu X, Tang Y, et al: miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Cancer Lett 344: 40-46, 2014.
19. Yamada S, Fuchs BC, Fujii T, et al: Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery 154: 946-954, 2013.
20. Hou P, Zhao Y, Li Z, et al: LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis 5: e1287, 2014.
21. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 8: 2289-2294, 2012.
22. Sun M, Liu XH, Wang KM, et al: Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer 13: 68, 2014.
23. Vitalone MJ, Naesens M, Sigdel T, Li L, Hseih S and Sarwal MM: The dual role of epithelial-to-mesenchymal transition in chronic allograft injury in pediatric renal transplantation. Transplantation 92: 787-795, 2011.
24. López-Novoa JM and Nieto MA: Inflammation and EMT: An alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1: 303-314, 2009.
25. Mucsi I and Rosivall L: Epithelial-mesenchymal transition in renal tubular cells in the pathogenesis of progressive tubulo-interstitial fibrosis. Acta Physiol Hung 94: 117-131, 2007.